The Changing NHS Environment for UK Market Access
The changing NHS environment brings unique challenges for UK market access. To ensure our Pharma and Medtech clients are always one step ahead, we strive to be as close as possible to the NHS.
To achieve this goal, we have an in-house team who specialise in NHS insights and UK market access, with experience working in the NHS, in UK market access and in industry.
We have also contracted with over 90+ associates who currently hold roles across the NHS, from CEO to HCA, as well as an increasing range on non-traditional and non-NHS roles.
Our unique NHS relationships guide and validate everything we do in the UK.
For your UK market access strategy to be successful, it is essential that you understand your customers. We provide unparalleled depth of insight into all areas of the NHS, from national policy through commissioning strategy to challenges on the front line of care delivery.
Our expert teams use these insights to inform, develop and validate HEOR strategies, health economic modelling, HTA submissions, customer communication materials and engaging digital communication aids.
How can NHS insights enhance your UK market access journey?
We partner with you to unlock opportunities and implement impactful market access campaigns.
We can apply insights directly into our UK market access projects or support you with specific education or insight sessions:
To discuss your UK market access strategy with our experts or to learn more about our NHS education and insights services, get in touch using the form below.
UK strategy and materials:
- Market access strategy in the changing NHS environment
- NHS engagement strategy
- HTA strategy
- Pathway mapping
- Development of customer-led value propositions that resonate with NHS decision-makes
- Creation of impactful communication tools that engage NHS budget-holders
Education:
- Bespoke updates on NHS policies and strategy relevant to your area of interest
- Continuing development of understanding through led educational programmes
- Dispelling myths and preconceptions about the NHS
- Bridging the gap between policy and theory, and how care is actually delivered
- Enhancing skills and techniques for engaging with the NHS
Insight:
- Engaging interested and thoughtful colleagues from within the NHS
- Validation of strategic principles and messaging with NHS stakeholders
- Interrogation and evaluation of product strategy and approach
- Facilitation of meetings, with and without HCPs, to achieve a range of objectives
- Broader strategic and tactical development
To discuss your UK market access strategy with our experts or to learn more about our NHS education and insights services, get in touch using the form below.
Why choose Mtech Access?
- We draw insights from a network of over 90 Associates currently working in NHS roles across the UK, covering 32 of the 42 integrated care systems in England, as well as Scotland and Wales
- Our network includes relationships with 3 Academic Health Science Networks (AHSNs)
- At Mtech Access, we have conducted 200+ NHS insights and education projects with 65+ clients*
- Our NHS Insight & Interaction team collectively have over 80 years’ experience in working in NHS and healthcare settings†
- Our knowledge of the NHS is utilised across all our UK-based projects
*Includes any distinct project for an external Pharmaceutical, Medtech, Biotech, Diagnostics or Healthcare client.
†Includes senior team members’ experience prior to joining Mtech Access.
- We draw insights from a network of over 80 Associates currently working in NHS roles across the UK, covering 32 of the 42 integrated care systems in England, as well as Scotland and Wales
- Our network includes relationships with 3 Academic Health Science Networks (AHSNs)
- At Mtech Access, we have conducted 135+ NHS insights and education projects with 40+ clients*
- Our NHS Insights & Interaction team collectively have over 100 years’ experience in working in NHS and healthcare settings†
- 8 team members have experience working in the NHS
- 5 team members currently hold executive, non-executive, or advisory roles in the NHS
- We have access to data and information that other consultancies don’t
- Our knowledge of the NHS is utilised across all our UK-based projects
*Includes any distinct project for an external Pharmaceutical, Medtech, Biotech, Diagnostics or Healthcare client.
†Includes senior team members’ experience prior to joining Mtech Access.
Understanding the evolving NHS
We can help you answer key questions related to the changing NHS. Contact us today to explore these questions and what they mean for your UK market access strategy with our team:
- How do we communicate with Integrated Care Systems (ICS), Places and Primary Care Networks (PCNs)?
- Who should we talk to in the NHS and what do they need to know?
- How do we get in front of ICS leads?
- How do we capture pathways of care?
- What are the threats and opportunities for our products?
- How do we move away from product-led conversations?
- Should we be having portfolio-level conversations with NHS leaders?
- Do we still need a value proposition and budget impact model to engage with the NHS?
Understanding the evolving NHS
We can help you answer key questions related to the changing NHS. Contact us today to explore these questions and what they mean for your UK market access strategy with our team:
- How do we communicate with Integrated Care Systems (ICS), Places and Primary Care Networks (PCNs)?
- Who should we talk to in the NHS and what do they need to know?
- How do we get in front of ICS leads?
- How do we capture pathways of care?
- What are the threats and opportunities for our products?
- How do we move away from product-led conversations?
- Should we be having portfolio-level conversations with NHS leaders?
- Do we still need a value proposition and budget impact model to engage with the NHS?
UK Market Access and NHS Customer Engagement
Are you ready to drive change in UK healthcare? Discover how we can support your UK Market Access strategy.
Featured Case Studies
-
Delivering a White Paper to highlight national variation in care, and propose solutions for improving care across the NHS
-
Understanding the diagnostic market access landscape in the UK
-
Understanding changing perceptions of value in the NHS
NHS and UK market access articles
So, what is happening with specialised commissioning in the NHS?
Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?…
How the life sciences industry can bring meaningful change to the NHS
How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium…
Collaboration is key to transforming NHS-industry relationships
Richard Marsh reflects on key themes from our NHS Transformation Symposium. He explores the operational and strategic challenges facing the NHS, the historic focus on inputs rather than outputs and the call put our by all our NHS speakers for a more collaborative relationship with and across industry…